Form 8-K - Current report:
SEC Accession No. 0001493152-19-009209
Filing Date
2019-06-14
Accepted
2019-06-14 16:09:11
Documents
1
Period of Report
2019-06-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8k.htm 8-K 26275
  Complete submission text file 0001493152-19-009209.txt   27604
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 19898975
SIC: 7389 Services-Business Services, NEC